LUNA-EMG to Enhance Motor Functions in Neurological Disorders (LUNA)
Primary Purpose
Stroke
Status
Recruiting
Phase
Not Applicable
Locations
Belgium
Study Type
Interventional
Intervention
LUNA-EMG
Sponsored by

About this trial
This is an interventional treatment trial for Stroke focused on measuring stroke, EMG, rehabilitation, physiotherapy, occupational therapy
Eligibility Criteria
Inclusion Criteria:
- Adult
- Having signed the informed consent
Exclusion Criteria:
- Acute pain syndrome
- Severe cognitive deficits
- Risk of fracture or unconsolidated fracture
- Rigid joints (spasticity, severe osteoarthritis and arthritis) or unstable joints
- Severe ataxia and apraxia
- Epilepsy
- Pacemakers and similar implants
- Insufficient skin conditions
Sites / Locations
- CNRFRecruiting
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
No Intervention
Arm Label
LUNA-EMG
Control
Arm Description
The experimental group will receive 30 minutes of training with the LUNA-EMG for 12 weeks.
The control group will receive its rehabilitation care.
Outcomes
Primary Outcome Measures
muscular strength in mV
muscular strength will be measured with the EMG
Secondary Outcome Measures
Fugl-Meyer
The scale evaluates motor capacities of the upper limb following a stroke. Scores range from 0 to 66 (the higher the better).
Modified Ashworth Scale
This scale measures spasticity. The results are scored from 0 to 4 (the higher the more spastic).
Lovett
This scale measures muscular strength. The scale ranges from 0 to 5 (the higher the better).
Full Information
NCT ID
NCT04716829
First Posted
January 19, 2021
Last Updated
May 9, 2023
Sponsor
University of Liege
Collaborators
Jean-François Kaux, MD PhD, Jordan Roncin
1. Study Identification
Unique Protocol Identification Number
NCT04716829
Brief Title
LUNA-EMG to Enhance Motor Functions in Neurological Disorders
Acronym
LUNA
Official Title
Study of the Efficacy of the LUNA-EMG System on Motor Function in the Management of Neurological Disorders.
Study Type
Interventional
2. Study Status
Record Verification Date
May 2023
Overall Recruitment Status
Recruiting
Study Start Date
March 1, 2021 (Actual)
Primary Completion Date
January 1, 2024 (Anticipated)
Study Completion Date
January 1, 2024 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Liege
Collaborators
Jean-François Kaux, MD PhD, Jordan Roncin
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
The aim of the present study is to evaluate the effects of training performed with the LUNA-EMG system to enhance motor functions of the upper limb in stroke This is a randomized open-label trial. Patients will be randomized into the intervention group (LUNA-EMG) or in the control group (standard care).
The effect of the training will be measured with the EMG, the upper limb motor function and the quality of life.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Stroke
Keywords
stroke, EMG, rehabilitation, physiotherapy, occupational therapy
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
60 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
LUNA-EMG
Arm Type
Experimental
Arm Description
The experimental group will receive 30 minutes of training with the LUNA-EMG for 12 weeks.
Arm Title
Control
Arm Type
No Intervention
Arm Description
The control group will receive its rehabilitation care.
Intervention Type
Device
Intervention Name(s)
LUNA-EMG
Intervention Description
The LUNA-EMG (Samcom) system is a robot that allows the evaluation of muscular strength through the recording of muscle activity (electromyography - EMG) in order to provide precise objective data on the patient's muscle function. In addition to the diagnostic aspect (evaluation of muscle strength, range of motion and proprioception), the LUNA-EMG robot allows the adaptation of movements during rehabilitation sessions according to the individually generated strength.
Primary Outcome Measure Information:
Title
muscular strength in mV
Description
muscular strength will be measured with the EMG
Time Frame
12 weeks
Secondary Outcome Measure Information:
Title
Fugl-Meyer
Description
The scale evaluates motor capacities of the upper limb following a stroke. Scores range from 0 to 66 (the higher the better).
Time Frame
12 weeks
Title
Modified Ashworth Scale
Description
This scale measures spasticity. The results are scored from 0 to 4 (the higher the more spastic).
Time Frame
12 weeks
Title
Lovett
Description
This scale measures muscular strength. The scale ranges from 0 to 5 (the higher the better).
Time Frame
12 weeks
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Adult
Having signed the informed consent
Exclusion Criteria:
Acute pain syndrome
Severe cognitive deficits
Risk of fracture or unconsolidated fracture
Rigid joints (spasticity, severe osteoarthritis and arthritis) or unstable joints
Severe ataxia and apraxia
Epilepsy
Pacemakers and similar implants
Insufficient skin conditions
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Aurore Thibaut
Phone
+324843612
Email
athibaut@uliege.be
First Name & Middle Initial & Last Name or Official Title & Degree
Jordan Roncin
Email
jroncins@chuliege.be
Facility Information:
Facility Name
CNRF
City
Tinlot
State/Province
Liege
ZIP/Postal Code
4557
Country
Belgium
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Aurore Thibaut
Email
athibaut@uliege.be
12. IPD Sharing Statement
Plan to Share IPD
Undecided
Learn more about this trial
LUNA-EMG to Enhance Motor Functions in Neurological Disorders
We'll reach out to this number within 24 hrs